Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/12/2007EP1863452A2 Bendamustine pharmaceutical compositions for lyophilisation
12/12/2007EP1863450A1 Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations
12/12/2007EP1863447A2 Nonsteroidal immunomodulating kit and composition and uses thereof
12/12/2007EP1863445A1 Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
12/12/2007EP1863433A1 Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition
12/12/2007EP1863432A1 Antibacterial 3',5-disubstituted 2,4'-dihydroxybiphenyl compounds, derivatives and related methods
12/12/2007EP1863356A1 Mixtures of fatty acid glycerides from c1 to c22 to improve zootechnical performances and/or the health of the intestine of animals
12/12/2007EP1758879B1 Method of manufacturing (s)-n-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine)
12/12/2007EP1752452A9 Propane-1,3-dione derivative or its salt
12/12/2007EP1718602A4 Therapeutic and carrier molecules
12/12/2007EP1687310B1 Method for the catalytic production of hydrocodone and hydromorphone
12/12/2007EP1682545B1 Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
12/12/2007EP1660500B1 Substituted imidazopyrimidines for the prevention and treatment of cancer
12/12/2007EP1644357B1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/12/2007EP1622579A4 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
12/12/2007EP1556058B1 Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy
12/12/2007EP1551824B1 Protein tyrosine kinase inhibitors
12/12/2007EP1549314B1 Use of brimonidine in the treatment of dementia and parkinsons disease
12/12/2007EP1505976B1 Synergistic combination of an opioid analgesic and a nsaid
12/12/2007EP1500656B1 Biguanide derivatives and their use as antidiabetic drugs
12/12/2007EP1496933A4 Use of interleukin-19 to treat ovarian cancer
12/12/2007EP1496880A4 SYNERGISTIC EFFECTS OF NUCLEAR TRANSCRIPTION FACTOR NF-kB INHIBITORS AND ANTI-NEOPLASTIC AGENTS
12/12/2007EP1492794B1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
12/12/2007EP1474414B1 Dihydro-thia-phenanthrene-carbonyl-guanidines, method for the production thereof, use thereof as a medicament or diagnostic reagent
12/12/2007EP1470120B1 N-oxyde of n-phenyl-2-pyrimidine-amine derivatives
12/12/2007EP1467712B1 Bilayer pharmaceutical tablet comprising telmisartan and hydrochlorothiazide
12/12/2007EP1442133B1 Use of Mirtazapine for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
12/12/2007EP1416942B1 Amine polymers for treating gout and binding uric acid
12/12/2007EP1406623B1 Substituted 1-phenethylpiperidine compounds used as inter alia analgesics
12/12/2007EP1399443B1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
12/12/2007EP1379227A4 Microemulsions as precursors to solid nanoparticles
12/12/2007EP1331927B1 Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
12/12/2007EP1327630B1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
12/12/2007EP1322294B1 Stabilization of solid thyroid drug formulations
12/12/2007EP1320356B1 Preparation of vitamin emulsions and concentrates thereof
12/12/2007EP1305022B1 Processes for the purification of tocopherol and/or sterol compounds and compositions containing orthoborate ester mixtures
12/12/2007EP1295601A4 Pharmaceutical composition based on a non-steroid anti-inflammatory agent
12/12/2007EP1276738B1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
12/12/2007EP1268481B1 Kinase inhibitors as therapeutic agents
12/12/2007EP1255456B1 Use of glutamate or of glutamic acid for the prevention of hyperpermeability or undesired permeability of the intestinal wall
12/12/2007EP1237859B1 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
12/12/2007EP1148779B1 Expression of secreted human alpha-fetoprotein in transgenic animals
12/12/2007EP1143943B1 USE OF p53 INHIBITORS FOR THE TREATMENT OF SIDE EFFECTS OF CANCER THERAPY
12/12/2007EP1030615B1 Spine distraction implant
12/12/2007EP1027004B1 Spine distraction implant
12/12/2007EP1000144B1 Lactoferrin receptor gene of moraxella
12/12/2007EP0932606B1 Inhibitors of prenyl transferases
12/12/2007EP0927174B1 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds
12/12/2007EP0894130B1 Modulators of tnf receptor associated factor (traf), their preparation and use
12/12/2007EP0893998B2 Colonic delivery of nicotine to treat inflammatory bowel disease
12/12/2007EP0888377B1 MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII)
12/12/2007EP0871434B2 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases
12/12/2007EP0819123B1 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity
12/12/2007EP0769967B1 Conjugates comprising an antitumour agent and their use
12/12/2007CN101087800A Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
12/12/2007CN101087798A Sulfonamido-macrocycles as tie2 inhibitors
12/12/2007CN101087797A Sulfonamido-macrocycles as tie2 inhibitors
12/12/2007CN101087795A Pharmaceutical compounds
12/12/2007CN101087794A Pharmaceutical compounds
12/12/2007CN101087793A Novel substituted thiophenepyrimidinone derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase
12/12/2007CN101087792A Synthetic process for preparing dual loop compound
12/12/2007CN101087791A Method for producing L-biopterin
12/12/2007CN101087790A Xanthine derivatives with hm74a receptor activity
12/12/2007CN101087789A Pyridine imidazoles and aza-indoles as progesterone receptor modulators
12/12/2007CN101087788A Quinoline derivative, its use, production and pharmaceutical agents containing the latter
12/12/2007CN101087787A Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents
12/12/2007CN101087786A Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents
12/12/2007CN101087785A 4-methoxy-pyrrolidine-2-carboxylic acid compounds and derivatives thereof as hepatitis c virus inhibitors
12/12/2007CN101087783A Trisubstituted thiophenes as progesterone receptor modulators
12/12/2007CN101087782A (2-carboxamido)(3-amino) thiophene compounds
12/12/2007CN101087781A Indole derivatives for treating pulmonary tuberculosis
12/12/2007CN101087780A Tricyclic amino alcohols, processes for synthesis of same and use of same as anti-inflammatory drugs
12/12/2007CN101087779A Selected benzofuran derivatives
12/12/2007CN101087778A Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors
12/12/2007CN101087777A Pyrrolidinium derivatives as M3 muscarinic receptors
12/12/2007CN101087775A Azole derivatives with antimuscarinic activity
12/12/2007CN101087773A Inhibitors of c-fms kinase
12/12/2007CN101087771A Substituted N-sulfonylaminobenzyl-2-phenoxyacetamide compounds
12/12/2007CN101087770A Tricyclic spacer systems for nonlinear optical devices
12/12/2007CN101087768A Thrombopoietin activity modulating compounds and methods
12/12/2007CN101087767A Fluorescent pyrazine derivatives and methods of using the same in assessing renal function
12/12/2007CN101087766A Pyridazine compounds, compositions and methods
12/12/2007CN101087765A Fused pyrazole derivatives and uses of methods of treatment of metabolic-related disorders thereof
12/12/2007CN101087764A Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents
12/12/2007CN101087763A Therapeutic agents
12/12/2007CN101087762A Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents
12/12/2007CN101087761A Tetracyclic indole derivatives as antiviral agents
12/12/2007CN101087760A Crystalline aripiprazole solvates
12/12/2007CN101087758A Indole derivatives useful as progesterone receptor modulators
12/12/2007CN101087757A Novel dipeptidyl peptidase iv inhibitors, process for their preparation and compositions containing them
12/12/2007CN101087756A 肽酶抑制剂 Peptidase inhibitors
12/12/2007CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007CN101087754A Novel cyclohexane derivatives
12/12/2007CN101087752A Novel ligands that modulate RAR receptors, and use thereof in human medicine and in cosmetics
12/12/2007CN101087623A Antisense oligonucleotides for treating allergy and neoplastic cell proliferation
12/12/2007CN101087619A Method of treatment or prophylaxis
12/12/2007CN101087615A N-acetylglucosamine tablet disintegrating in oral cavity and process for producing the same
12/12/2007CN101087614A New use of GABAbeta receptor agonists
12/12/2007CN101087613A Preventing or treating agent for glaucoma
12/12/2007CN101087612A Oral immediate release formulation of a poorly watersoluble active substance
1 ... 3464 3465 3466 3467 3468 3469 3470 3471 3472 3473 3474 3475 3476 3477 3478 3479 3480 3481 3482 3483 3484 ... 7860